Healthcare provider profile · identity verified

Deepkamal Kaur, M.D.

Internal Medicine · BARRINGTON, IL · NPI 1538477435

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	523	157
Levothyroxine Sodium	Levothyroxine Sodium	478	122
Lisinopril	Lisinopril	373	105
Losartan Potassium	Losartan Potassium	331	90
Amlodipine Besylate	Amlodipine Besylate	321	104
Metoprolol Succinate	Metoprolol Succinate	252	73
Hydrochlorothiazide	Hydrochlorothiazide	239	72
Rosuvastatin Calcium	Rosuvastatin Calcium	228	67
Omeprazole	Omeprazole	192	56
Metformin Hcl	Metformin Hcl	167	45
Pantoprazole Sodium	Pantoprazole Sodium	152	52
Simvastatin	Simvastatin	145	44
Escitalopram Oxalate	Escitalopram Oxalate	144	36
Metformin Hcl Er	Metformin Hcl	141	39
Furosemide	Furosemide	133	44
Alprazolam	Alprazolam	125	44
Gabapentin	Gabapentin	120	36
Trazodone Hcl	Trazodone Hcl	116	32
Sertraline Hcl	Sertraline Hcl	115	33
Metoprolol Tartrate	Metoprolol Tartrate	103	36
Tamsulosin Hcl	Tamsulosin Hcl	103	33
Potassium Chloride	Potassium Chloride	97	27
Allopurinol	Allopurinol	95	31
Tramadol Hcl	Tramadol Hcl	95	15
Pravastatin Sodium	Pravastatin Sodium	89	30
Zolpidem Tartrate	Zolpidem Tartrate	89	23
Famotidine	Famotidine	86	23
Carvedilol	Carvedilol	83	21
Glipizide	Glipizide	78	22
Ozempic	Semaglutide	78	21
Clopidogrel	Clopidogrel Bisulfate	73	18
Meloxicam	Meloxicam	73	29
Montelukast Sodium	Montelukast Sodium	70	23
Azithromycin	Azithromycin	69	49
Azelastine Hcl	Azelastine Hcl	65	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	65	23
Albuterol Sulfate Hfa	Albuterol Sulfate	60	25
Lorazepam	Lorazepam	57	12
Synthroid	Levothyroxine Sodium	57	14
Fluoxetine Hcl	Fluoxetine Hcl	54	12
Spironolactone	Spironolactone	53	14
Methylprednisolone	Methylprednisolone	52	45
Celecoxib	Celecoxib	51	16
Eliquis	Apixaban	46	19
Fluticasone Propionate	Fluticasone Propionate	46	17
Jardiance	Empagliflozin	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	12
Warfarin Sodium	Warfarin Sodium	42	suppressed
Atenolol	Atenolol	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	12
Clonazepam	Clonazepam	37	suppressed
Alendronate Sodium	Alendronate Sodium	36	11
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Bupropion Xl	Bupropion Hcl	36	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Lovastatin	Lovastatin	30	suppressed
Bumetanide	Bumetanide	27	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Finasteride	Finasteride	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Diazepam	Diazepam	25	11
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Prednisone	Prednisone	25	11
Glimepiride	Glimepiride	24	suppressed
Valsartan	Valsartan	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Lamotrigine Er	Lamotrigine	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Estradiol	Estradiol	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	14
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Pregabalin	Pregabalin	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Colestipol Hcl	Colestipol Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Larin Fe	Norethindrone-E.Estradiol-Iron	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error